Lexicon Pharmaceuticals
LXRX
#7492
Rank
ยฃ0.30 B
Marketcap
ยฃ0.85
Share price
-19.44%
Change (1 day)
42.78%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -ยฃ53.62 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ70.86 Million. In 2024 the company made an earning of -ยฃ0.15 Billion a decrease over its 2023 earnings that were of -ยฃ0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ53.62 Million-63.4%
2024 -ยฃ0.15 Billion13.15%
2023 -ยฃ0.13 Billion73.74%
2022 -ยฃ74.53 Million16.16%
2021 -ยฃ64.16 Million49.82%
2020 -ยฃ42.82 Million-147.19%
2019 ยฃ90.73 M-203.42%
2018 -ยฃ87.74 Million-15.31%
2017 -ยฃ0.11 Billion0.2%
2016 -ยฃ0.11 Billion2920.7%
2015 -ยฃ3.43 Million-95.33%
2014 -ยฃ73.37 Million-3.61%
2013 -ยฃ76.12 Million-5.52%
2012 -ยฃ80.57 Million-4.17%
2011 -ยฃ84.08 Million15.5%
2010 -ยฃ72.8 Million8.36%
2009 -ยฃ67.18 Million-4.81%
2008 -ยฃ70.57 Million28.79%
2007 -ยฃ54.8 Million35.71%
2006 -ยฃ40.38 Million52.91%
2005 -ยฃ26.41 Million-23.89%
2004 -ยฃ34.69 Million-24.19%
2003 -ยฃ45.76 Million-0.48%
2002 -ยฃ45.98 Million44.12%
2001 -ยฃ31.91 Million23.01%
2000 -ยฃ25.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ5.18 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ0.72 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ3.76 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.38 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ48.82 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ20.06 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ16.99 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.49 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ6.94 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA